Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 Trials

Stephen Jolles, Mikhail A. Rojavin, John Philip Lawo, Robert Nelson, Richard L. Wasserman, Michael Borte, Michael A. Tortorici, Kohsuke Imai, Hirokazu Kanegane

Research output: Contribution to journalArticle

4 Scopus citations

Fingerprint Dive into the research topics of 'Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 Trials'. Together they form a unique fingerprint.

Medicine & Life Sciences